SOLIUS Competitors and Similar CompaniesClear all

ReShape Lifesciences's competitors and similar companies include ElectroCore.
ReShape Lifesciences
ReShape Lifesciences
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
ElectroCore
ElectroCore
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
Founding Date
Founding Date
2002
Founding Date
2005
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Clemente, US HQ
San Clemente, US
Locations
Rockaway, US HQ
Parksville, CA
Geretsried, DE
Hamburg, DE
Yeadon, GB
Bernards, US
Employees
Employees
4348% decrease
Employees
5144% decrease
Valuation ($)
Valuation ($)
3 m
Valuation ($)
71.2 m

Financial

Revenue (est.)
Revenue (est.)
$11.3m (FY, 2020)
Revenue (est.)
$32m (FY, 2025)
Cost of goods
Cost of goods
$5m (FY, 2020)
Cost of goods
$4.2m (FY, 2025)
Gross profit
Gross profit
$6.3m (FY, 2020)
Gross profit
$27.8m (FY, 2025)
Net income
Net income
($21.6m) (FY, 2020)
Net income
($14m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

ElectroCore
HQ
Rockaway, US
Employees
51↓ 44% decrease

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

View company